In fact, breast carcinomas that co-express E- and P-cadherin show a patient survival that is worse than that associated with breast carcinomas that express only one of the cadherins or that do not express any of these adhesion molecules [58, 77]. This evidence concerns the gene CDH17 and breast carcinoma.